» Articles » PMID: 23425659

The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) Suppresses Multiple Pro-inflammatory Mast Cell Effector Functions

Overview
Publisher Biomed Central
Date 2013 Feb 22
PMID 23425659
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of mast cells (MCs) can be achieved by the high-affinity receptor for IgE (FcεRI) as well as by additional receptors such as the lipopolysaccharide (LPS) receptor and the receptor tyrosine kinase Kit (stem cell factor [SCF] receptor). Thus, pharmacological interventions which stabilize MCs in response to different receptors would be preferable in diseases with pathological systemic MC activation such as systemic mastocytosis. 1,4-Benzodiazepines (BDZs) have been reported to suppress MC effector functions. In the present study, our aim was to analyze molecularly the effects of BDZs on MC activation by comparison of the effects of the two BDZs Ro5-4864 and clonazepam, which markedly differ in their affinities for the archetypical BDZ recognition sites, i.e., the GABAA receptor and TSPO (previously termed peripheral-type BDZ receptor). Ro5-4864 is a selective agonist at TSPO, whereas clonazepam is a selective agonist at the GABAA receptor. Ro5-4864 suppressed pro-inflammatory MC effector functions in response to antigen (Ag) (degranulation/cytokine production) and LPS and SCF (cytokine production), whereas clonazepam was inactive. Signaling pathway analyses revealed inhibitory effects of Ro5-4864 on Ag-triggered production of reactive oxygen species, calcium mobilization and activation of different downstream kinases. The initial activation of Src family kinases was attenuated by Ro5-4864 offering a molecular explanation for the observed impacts on various downstream signaling elements. In conclusion, BDZs structurally related to Ro5-4864 might serve as multifunctional MC stabilizers without the sedative effect of GABAA receptor-interacting BDZs.

Citing Articles

CD3ζ-Mediated Signaling Protects Retinal Ganglion Cells in Glutamate Excitotoxicity of the Retina.

Du R, Wang P, Tian N Cells. 2024; 13(12.

PMID: 38920637 PMC: 11201742. DOI: 10.3390/cells13121006.


Longitudinal cytokine and multi-modal health data of an extremely severe ME/CFS patient with HSD reveals insights into immunopathology, and disease severity.

Jahanbani F, Sing J, Maynard R, Jahanbani S, Dafoe J, Dafoe W Front Immunol. 2024; 15:1369295.

PMID: 38650940 PMC: 11033372. DOI: 10.3389/fimmu.2024.1369295.


Mitochondrial translocator protein deficiency exacerbates pathology in acute experimental ulcerative colitis.

Jimenez I, Stilin A, Morohaku K, Hussein M, Koganti P, Selvaraj V Front Physiol. 2022; 13:896951.

PMID: 36060674 PMC: 9437295. DOI: 10.3389/fphys.2022.896951.


Use of benzodiazepines is the risk factor for infection in patients aged 80 years or older with diffuse large B-cell lymphoma: A single-institution retrospective study.

Ogiso A, Mizuno T, Ito K, Mizokami F, Tomita A, Yamada S PLoS One. 2022; 17(6):e0269362.

PMID: 35687536 PMC: 9187058. DOI: 10.1371/journal.pone.0269362.


A comprehensive review of remimazolam for sedation.

Noor N, Legendre R, Cloutet A, Chitneni A, Varrassi G, Kaye A Health Psychol Res. 2021; 9(1):24514.

PMID: 34746482 PMC: 8567764. DOI: 10.52965/001c.24514.


References
1.
Scheid M, Huber M, Damen J, Hughes M, Kang V, Neilsen P . Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation; phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase.... J Biol Chem. 2002; 277(11):9027-35. DOI: 10.1074/jbc.M106755200. View

2.
Santidrian A, Cosialls A, Coll-Mulet L, Iglesias-Serret D, de Frias M, Gonzalez-Girones D . The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells. Haematologica. 2007; 92(12):1631-8. DOI: 10.3324/haematol.11194. View

3.
Strohmeier R, Roller M, Sanger N, Knecht R, Kuhl H . Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cells. Biochem Pharmacol. 2002; 64(1):99-107. DOI: 10.1016/s0006-2952(02)01059-6. View

4.
Molderings G, Brettner S, Homann J, Afrin L . Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol. 2011; 4:10. PMC: 3069946. DOI: 10.1186/1756-8722-4-10. View

5.
Galanos C, LUDERITZ O, Westphal O . A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969; 9(2):245-9. DOI: 10.1111/j.1432-1033.1969.tb00601.x. View